abstract |
The present invention pertains to tetracycline compounds of formula (VIIa): n n n n n n n n n n R 5* , R 5*′ , R 7r* , and R 9m* are defined herein. These tetracycline compounds can be used to treat tetracycline compound-responsive states, such as multiple sclerosis and rheumatoid arthritis. |